Terms: = Sarcomas AND PMS2, HNPCC4, 5395, ENSG00000122512, H_DJ0042M02_9, PMSL2, PMS2CL AND Diagnosis
426 results:
1. Associations Between Stress, Health Behaviors, and Quality of Life in Young Couples During the Transition to Survivorship: Protocol for a Measurement Burst Study.
Cho D; Roth M; Peterson SK; Jennings K; Kim S; Weathers SP; Ahmed S; Livingston JA; Barcenas C; You YN; Milbury K
JMIR Res Protoc; 2024 Apr; 13():e53307. PubMed ID: 38652520
[TBL] [Abstract] [Full Text] [Related]
2. Clinical characteristics, molecular aberrations, treatments, and outcomes of malignant histiocytosis.
Ruan GJ; Zanwar S; Ravindran A; Schram S; Abeykoon JP; Hazim A; Young JR; Shah MV; Bennani NN; Jiang L; Morlote D; Rech KL; Goyal G; Go RS;
Am J Hematol; 2024 May; 99(5):871-879. PubMed ID: 38409747
[TBL] [Abstract] [Full Text] [Related]
3. Image-guided percutaneous ablation of hepatic epithelioid hemangioendothelioma.
Hu EY; Bhagavatula SK; Shi A; Merriam P; Levesque VM; Shyn PB
Abdom Radiol (NY); 2024 Apr; 49(4):1241-1247. PubMed ID: 38240859
[TBL] [Abstract] [Full Text] [Related]
4. Clinico-Genomic Profiling of Conventional and Dedifferentiated Chondrosarcomas Reveals TP53 Mutation to Be Associated with Worse Outcomes.
Denu RA; Yang RK; Lazar AJ; Patel SS; Lewis VO; Roszik J; Livingston JA; Wang WL; Shaw KR; Ratan R; Zarzour MA; Bird J; Raza S; Akdemir KC; Rodon Ahnert J; Subbiah V; Patel S; Conley AP
Clin Cancer Res; 2023 Dec; 29(23):4844-4852. PubMed ID: 37747813
[TBL] [Abstract] [Full Text] [Related]
5. [CIC-rearranged sarcoma: a clinicopathological analysis of four cases].
Wan X; Tang JL; Li X; Wang C; Li H; Pan MH
Zhonghua Bing Li Xue Za Zhi; 2023 Jul; 52(7):690-695. PubMed ID: 37408399
[No Abstract] [Full Text] [Related]
6. Hepatic Angiosarcomas With Sinusoidal Growth Patterns.
Soon GST; Chen ZE; Wu TT; Torbenson MS; Yasir S
Am J Surg Pathol; 2023 Sep; 47(9):1045-1051. PubMed ID: 37357916
[TBL] [Abstract] [Full Text] [Related]
7. [Clinicopathological and gene mutation characteristics of uterine carcinosarcoma].
Tu J; Xu JZ; Zhang YS; Deng LF
Zhonghua Yi Xue Za Zhi; 2023 Jun; 103(24):1864-1867. PubMed ID: 37357193
[TBL] [Abstract] [Full Text] [Related]
8. Same-day testing with initiation of antiretroviral therapy or tuberculosis treatment versus standard care for persons presenting with tuberculosis symptoms at HIV diagnosis: A randomized open-label trial from Haiti.
Dorvil N; Rivera VR; Riviere C; Berman R; Severe P; Bang H; Lavoile K; Devieux JG; Faustin M; Saintyl G; Mendicuti MD; Pierre S; Apollon A; Dumond E; Forestal GPL; Rouzier V; Marcelin A; McNairy ML; Walsh KF; Dupnik K; Reif LK; Byrne AL; Bousleiman S; Orvis E; Joseph P; Cremieux PY; Pape JW; Koenig SP
PLoS Med; 2023 Jun; 20(6):e1004246. PubMed ID: 37294843
[TBL] [Abstract] [Full Text] [Related]
9. Novel characteristics for immunophenotype, FISH pattern and molecular cytogenetics in synovial sarcoma.
Zhong LL; Huang GX; Xian LY; Wei ZC; Tang ZP; Chen QY; Chen H; Tang F
Sci Rep; 2023 May; 13(1):7954. PubMed ID: 37193761
[TBL] [Abstract] [Full Text] [Related]
10. Cumulative burden of late, major surgical intervention in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study (CCSS) cohort.
Dieffenbach BV; Murphy AJ; Liu Q; Ramsey DC; Geiger EJ; Diller LR; Howell RM; Oeffinger KC; Robison LL; Yasui Y; Armstrong GT; Chow EJ; Weil BR; Weldon CB
Lancet Oncol; 2023 Jun; 24(6):691-700. PubMed ID: 37182536
[TBL] [Abstract] [Full Text] [Related]
11. Risk of second primary cancer among women in the Kaiser Permanente Breast Cancer Survivors Cohort.
Ramin C; Veiga LHS; Vo JB; Curtis RE; Bodelon C; Aiello Bowles EJ; Buist DSM; Weinmann S; Feigelson HS; Gierach GL; Berrington de Gonzalez A
Breast Cancer Res; 2023 May; 25(1):50. PubMed ID: 37138341
[TBL] [Abstract] [Full Text] [Related]
12. Risk Factors and Trends for HPV-Associated Subsequent Malignant Neoplasms among Adolescent and Young Adult Cancer Survivors.
Ou JY; Bennion N; Parker K; Fair D; Hanson HA; Kepka D; Warner EL; Ramsay JM; Kaddas HK; Kirchhoff AC
Cancer Epidemiol Biomarkers Prev; 2023 May; 32(5):625-633. PubMed ID: 37071501
[TBL] [Abstract] [Full Text] [Related]
13. Expression of SATB2 in primary cutaneous sarcomatoid neoplasms: a potential diagnostic pitfall.
Szczepanski JM; Siddiqui J; Patel RM; Harms PW; Hrycaj SM; Chan MP
Pathology; 2023 Apr; 55(3):350-354. PubMed ID: 36732203
[TBL] [Abstract] [Full Text] [Related]
14. Circulating Tumor DNA Is Prognostic in Intermediate-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group.
Abbou S; Klega K; Tsuji J; Tanhaemami M; Hall D; Barkauskas DA; Krailo MD; Cibulskis C; Nag A; Thorner AR; Pollock S; Imamovic-Tuco A; Shern JF; DuBois SG; Venkatramani R; Hawkins DS; Crompton BD
J Clin Oncol; 2023 May; 41(13):2382-2393. PubMed ID: 36724417
[TBL] [Abstract] [Full Text] [Related]
15. Risk of early death in adolescents and young adults with cancer: a population-based study.
Berkman AM; Andersen CR; Hildebrandt MAT; Livingston JA; Green AL; Puthenpura V; Peterson SK; Milam J; Miller KA; Freyer DR; Roth ME
J Natl Cancer Inst; 2023 Apr; 115(4):447-455. PubMed ID: 36682385
[TBL] [Abstract] [Full Text] [Related]
16. Cell-Free DNA as a Diagnostic and Prognostic Biomarker in Pediatric Rhabdomyosarcoma.
Lak NSM; van Zogchel LMJ; Zappeij-Kannegieter L; Javadi A; van Paemel R; Vandeputte C; De Preter K; De Wilde B; Chicard M; Iddir Y; Schleiermacher G; Ruhen O; Shipley J; Fiocco M; Merks JHM; van Noesel MM; van der Schoot CE; Tytgat GAM; Stutterheim J
JCO Precis Oncol; 2023 Jan; 7():e2200113. PubMed ID: 36652664
[TBL] [Abstract] [Full Text] [Related]
17. Lymph node metastases in paediatric and young adult patients with non-rhabdomyosarcoma soft tissue sarcoma (NRSTS): Findings from Children's Oncology Group (COG) study ARST0332.
Alvarez E; He J; Spunt SL; Hayes-Jordan A; Kao SC; Parham DM; Million L; Weiss AR; Barkauskas DA
Eur J Cancer; 2023 Feb; 180():89-98. PubMed ID: 36566574
[TBL] [Abstract] [Full Text] [Related]
18. Efficacy of immunotherapy with combination of cryotherapy and topical imiquimod for treatment of Kaposi sarcoma.
Gu L; Lin E; Liu S; Yang N; Kurtansky N; Neumann NM; Stoll J; Lezcano C; Pulitzer M; Noor S; Markova A; Rossi A; Dickson MA; Deng L
J Med Virol; 2023 Jan; 95(1):e28396. PubMed ID: 36504005
[TBL] [Abstract] [Full Text] [Related]
19. Risk of venous thromboembolism and major bleeding in the clinical course of osteosarcoma and Ewing sarcoma.
Kaptein FHJ; Stals MAM; Evenhuis RE; Gelderblom H; Huisman MV; Karis DSA; Noten RWD; Cannegieter SC; Speetjens FM; Verschoor AJ; Versteeg HH; van de Sande MAJ; Klok FA
Thromb Res; 2023 Jan; 221():19-25. PubMed ID: 36435048
[TBL] [Abstract] [Full Text] [Related]
20. Patients with completely resected nongenitourinary low-risk embryonal rhabdomyosarcoma are candidates for reduced duration low-intensity chemotherapy.
Bisogno G; Fuchs J; Dasgupta R; Ferrari A; Haduong JH; Rogers T; Walterhouse DO; Coppadoro B; Xue W; Vokuhl C; Hawkins DS; Seitz G; Merks JHM; Sparber-Sauer M; Venkatramani R
Cancer; 2022 Dec; 128(23):4150-4156. PubMed ID: 36250420
[TBL] [Abstract] [Full Text] [Related]
[Next]